DIFFERENT INDUCTION RESPONSE CRITERIA DO NOT INFLUENCE 1 YEAR RESPONSE AND REMISSION RATES OF USTEKINUMAB 90 MG Q8W IN PHASE III PROGRAM

Dominik Naessens  1     Jewel Johanns  2     Christopher Gasink  2    
1 Janssen-Cilag, Beerse, Belgium
2 Janssen Research and Development, LLC, Spring House, United States of America

Conference
UEG Week 2016

Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing